Organigram Posts Wider Loss, Eyes Profitability In Near Term
Cannabis grower Organigram Holdings Inc. (NASDAQ:OGI) reported third-quarter 2025 net sales of $51.14 million, approximately $70.8 million Canadian dollars (CAD), up 72% year-over-year, beating the consensus of $48.33 million.
$59.92 million (85%) was attributable to recreational cannabis sales.
The increase was primarily driven by contributions from the acquisition of Motif Labs and increased international sales. Gross revenue increased 73% to $110.2 million.
The volume of flower sales in grams increased 24% to 23,290 kg in the quarter, compared to 18,785 kg a year ago. This growth was primarily driven by the success of the company’s large-format value products, a significant increase in international sales, and higher sales of infused pre-rolls.
OrganiGram reported a loss of 3 cents, missing the consensus of a loss of one cent.